de la Torre A. Evolving role of novel therapies in myeloma: T-cell engagers and antibody-drug conjugates. Can Hematol Today [Internet]. 2023 Jun. 7 [cited 2024 Oct. 18];2(2):16–19. Available from: https://canadianhematologytoday.com/article/view/2-2-de_la_Torre